TELA:NASDAQTELA Bio, Inc. Analysis
Data as of 2026-05-04 - not real-time
$1.14
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: TELA Bio is trading above its short‑term moving averages but remains below the long‑term average, signaling short‑term momentum amid a broader bearish backdrop. Momentum indicators are in overbought territory and the MACD has turned bullish, while volume is on the rise, suggesting a potentially fragile rally.
Fundamental outlook: The company delivers solid revenue growth and impressive gross margins, yet it continues to post operating losses, negative cash flow and a debt load that dwarfs its equity. A recent board refresh bringing seasoned commercial leaders and the release of preliminary Q1 revenue aim to steer the business toward profitability, providing a growth narrative despite the financial strain.
Fundamental outlook: The company delivers solid revenue growth and impressive gross margins, yet it continues to post operating losses, negative cash flow and a debt load that dwarfs its equity. A recent board refresh bringing seasoned commercial leaders and the release of preliminary Q1 revenue aim to steer the business toward profitability, providing a growth narrative despite the financial strain.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Overbought momentum indicator
- Price below long‑term average
- Elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Board refresh with commercial expertise
- Continued revenue growth
- High cash burn and debt burden
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Strong gross margin profile
- Niche market position in soft‑tissue reconstruction
- Potential path to profitability with execution of growth plan
Key Metrics & Analysis
Financial Health
Revenue Growth18.20%
Profit Margin-48.37%
P/E Ratio-2.0
ROE-223.35%
ROA-25.12%
Debt/Equity913.26
P/B Ratio8.0
Op. Cash Flow$-28219000
Free Cash Flow$-16954000
Industry P/E25.5
Technical Analysis
TrendBearish
RSI75.8
Support$0.55
Resistance$1.16
MA 20$0.72
MA 50$0.74
MA 200$1.19
MACDBullish
VolumeIncreasing
Fear & Greed Index89.04
Valuation
Target Price$2.25
Upside/Downside97.37%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.55
Volatility139.96%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.